Australia’s top brokers have been busy adjusting their estimates and recommendations once again. This has led to the release of a number of broker notes.
Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
Catapult Group International Ltd (ASX: CAT)
According to a note out of Morgans, its analysts have retained their add rating and lifted their price target on this sports analytics and wearables company’s shares to $2.46. The broker made the move following the release of Catapult’s full year results for FY 2021 earlier this week. Morgans was pleased with its second half annualised contract value (ACV) growth and its low churn. The Catapult share price is trading at $2.19 this afternoon.
Costa Group Holdings Ltd (ASX: CGC)
A note out of Credit Suisse reveals that its analysts have upgraded this horticulture company’s shares to an outperform rating but cut the price target on them to $4.15. According to the note, Credit Suisse believes that Costa’s disappointing first half guidance has been driven by seasonal factors rather than structural issues. In light of this and the sharp pullback in its share price yesterday, the broker sees value in its shares at the current level. The Costa share price is fetching $3.40 on Friday.
Ramsay Health Care Limited (ASX: RHC)
Analysts at Macquarie have retained their outperform rating and $74.85 price target on this private hospital operator’s shares. According to the note, the broker sees positives from the company’s plan to acquire UK-based Spire Healthcare for 1 billion pounds ($1.8 billion). Macquarie believes the deal will provide strategic and financial benefits, as well as support its long term growth in the UK market. The Ramsay share price is trading at $63.22 on Friday afternoon.